{{Rsnum
|rsid=1052912
|Gene=TNFAIP2
|Chromosome=14
|position=103137316
|Orientation=plus
|GMAF=0.09458
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TNFAIP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 19.5 | 80.5
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 4.8 | 31.3 | 63.9
| ASW | 7.0 | 40.4 | 52.6
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 13.9 | 85.1
| LWK | 0.9 | 36.4 | 62.7
| MEX | 1.7 | 22.4 | 75.9
| MKK | 3.2 | 32.7 | 64.1
| TSI | 2.0 | 16.7 | 81.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=21934093
|Title=A Functional Variant at the miR-184 Binding Site in TNFAIP2 and Risk of Squamous Cell Carcinoma of the Head and Neck
|OA=1
}}

{{PMID Auto
|PMID=23724109
|Title=The miR-184 Binding-Site rs8126 T&gt;C Polymorphism in TNFAIP2 Is Associated with Risk of Gastric Cancer
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}